Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Posterior capsule opacification
ADR ID BADD_A03516
ADR Hierarchy
12      Injury, poisoning and procedural complications
12.02      Procedural related injuries and complications NEC
12.02.02      Eye and ear procedural complications
12.02.02.002      Posterior capsule opacification
06      Eye disorders
06.06      Anterior eye structural change, deposit and degeneration
06.06.05      Lens structural change, deposit and degeneration (excl cataracts)
06.06.05.001      Posterior capsule opacification
Description Clouding or loss of transparency of the posterior lens capsule, usually following CATARACT extraction. [MeSH]
MedDRA Code 10036346
MeSH ID D058442
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
After-cataract | After-cataract, obscuring vision | After-cataract, unspecified | Other after-cataract, not obscuring vision | Posterior capsule opacification | Secondary cataract | Soemmering's ring | Aftercataract | Posterior capsule plaque | Posterior capsule fibrosis | Capsular haze | Posterior capsular wrinkles | Posterior capsular thickening | Capsule Opacification | Capsule Opacifications | Opacification, Capsule | Opacifications, Capsule | Secondary Cataract | Cataract, Secondary | Cataracts, Secondary | Secondary Cataracts
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00623Dexamethasone0.000509%
BADD_D00667Difluprednate--
BADD_D01912Ranibizumab--
BADD_D02272Triamcinolone acetonide0.000027%
BADD_D02464Fingolimod0.000241%
The 1th Page    1    Total 1 Pages